Skip to content

Exploring the Impact of Diabetes on the Occurrence and Development of Endometrial Cancer

Exploring the Impact of Diabetes on the Occurrence and Development of Endometrial Cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500099409
Enrollment
Unknown
Registered
2025-03-24
Start date
2025-03-24
Completion date
Unknown
Last updated
2025-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial cancer

Interventions

With diabetes mellitus group:None
Diabetes-free group:None

Sponsors

The First Affiliated Hospital of Ningbo University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with endometrial cancer by pathology. 2. Age 18 years and older. 3. Patients with diabetes mellitus should have a clear history of diabetes diagnosis and stable blood glucose control. 4. Patients without diabetes mellitus should be excluded from diabetes through clinical examination. 5. Patients voluntarily participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with other malignant tumors. 2. Patients with severe heart, liver, and kidney dysfunction. 3. Patients with a history of psychiatric illness or cognitive impairment who are unable to understand the content of the study and sign the informed consent form. 4. Patients who are participating in other clinical trials that may affect the results of this study. 5. Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
Endometrial tissue sequencing;Immunohistochemical cellular protein expression;Intracellular nucleic acid expression level;

Countries

China

Contacts

Public ContactGuan Yutao

The First Affiliated Hospital of Ningbo University

2309732100@qq.com+86 135 6603 6278

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026